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Developments in digital health has the potential to transform the delivery of health 
and social care to help citizens manage their own health. Currently there is a lack 
consensus about digital health research priorities in palliative care and a lack 
theories about how these technologies might improve care outcomes. Therefore, it is 
important for healthcare leaders to identify innovations to ensure that an increasingly 
frail population have appropriate access to palliative care services. Consequently, it 
is important to articulate research priorities as the first step to determine how we 
should allocate finite resources to a field saturated with rapidly developing 
innovations.  
Objective 
To identify research priority areas for digital health in palliative care. 
Methods 
We selected the digital health trends, most relevant to palliative care, from a list of 
emerging trends reported by a world-leading Institute of quantitative futurists. We 
conducted two rounds of Delphi questionnaire, followed by a consensus meeting and 
a public engagement workshop to establish final consensus on research priorities for 
digital technology in palliative care. We used the views of public representatives to 
gain their perspectives of the agreed priorities. 
Results 
One hundred and three experts (representing 11 countries) participated in the 1st 
Delphi round. Fifty-five participated in the 2nd round (53% of 1st round). Eleven 
experts attended the final consensus meeting. We identified 16 priorities areas, 
which involved many applications of technologies, including care for patients and 
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caregivers, self-management and reporting of disease, education and training, 
communication, care coordination and research methodology. We summarised the 
priority areas into eight topic areas, which were: big data, mobile devices, telehealth 
and telemedicine, virtual reality, artificial intelligence, the smart home, biotechnology 
and digital legacy. 
Conclusions 
The identified priorities in this paper represent a wide range of important emerging 
areas in field of digital health, personalised medicine, and data science. Human-
centred design and robust governance systems should be considered in future 
research. It is important that the risks of using these technologies in palliative care 
are properly addressed to ensure that these tools are used meaningfully, wisely and 
safely and do not cause unintentional harm. 
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Developments in digital health (describing technologies which use computing 
platforms, connectivity, software, and sensors for health care and related purposes) 
has the potential to transform the delivery of health and social care to help citizens 
manage their own health.[1-3] Currently, we lack consensus about digital health 
research priorities in palliative care and lack theories about how these technologies 
might improve care outcomes. Therefore, it is important to articulate research 
priorities as the first step to determine how we should allocate finite resources to a 
field saturated with rapidly developing innovations. Global palliative care need is 
expected to increase due to the consequences of an ageing population; therefore, it 
is important for healthcare leaders to identify innovations to ensure that an 
increasingly frail population have appropriate access to palliative care services.[4] 
Research demonstrates that, when used well, digital health initiatives improve 
healthcare delivery and access,[5-15] and the World Health Organisation (WHO) 
promotes that digital health should be an integral part of health priorities as a means 
to improve health on a global scale.[16] [17] To date, many barriers have prevented 
the meaningful use of digital health in palliative care;[18] these barriers include 
expense, inter-operability issues, data privacy and security concerns, lack of 
effectiveness, equity, and the concern that technology will reduce face-to-face 
consults between patients and clinicians.[19, 20]  
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Strategic forethought (futurism) can help palliative care leaders to recognise 
emerging trends, to test, plan and use these innovations in 
practice.[21] Consequently, this study aims to identify digital health research 
priorities and to theorize how innovations in emerging technologies can improve 
palliative care. 
Aim 





We used a Delphi process, informed by the guidance on conducting and reporting 
Delphi studies (Guidance on Conducting and REporting DElphi Studies - 
CREDES[22]) in palliative care, to establish the opinion of palliative care experts. A 
Delphi process can be used as a consensus-based, forecasting process, enabling 
anonymous expert contributions to predict phenomena.[23, 24] We chose to use the 
Delphi method for its potential to achieve consensus in areas of uncertainty.[25-28] 
We conducted two rounds of Delphi questionnaire, followed by a consensus meeting 
and a public engagement workshop to establish final consensus on research 
priorities for digital technology in palliative care. Data collection took place between 
November 2018 and September 2019.  
 
Identification of technology trends from the Future Today Institute 
We selected technology trends most relevant to palliative care from a list of 
emerging technology trends reported by the Future Today Institute.[29] The FTI is a 
multi-professional organisation that uses data-driven applied research to develop 
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models that forecast risk and opportunity across several disciplines, which are 
mapped into technology trends. The 2018 trend list included 225 emerging trends, 
which was stratified by the FTI authors into 19 categories (Appendix 1: Future Today 
Institute 2018 Trends list).  
 
Selection of technology trends for palliative care 
We developed criteria to select the FTI trends, based on recommendations from a 
UK-based policy report, which reported public and professional views on new types 
of healthcare data.[30] We developed the following statement to select FTI trends for 
inclusion: ‘Trends should involve analysis or use data generated by a patient, 
caregiver or healthcare professional with potential use in palliative care’. Two 
authors (ACN and TMc) reviewed all 225 FTI trends. We chose to review all the FTI 
trends (despite their prior categorisation) to ensure that no suitable trends, from 
categories deemed less relevant to palliative care (e.g., agricultural technologies, 
space and government and technology policy), were overlooked. We included 95 
(42.2.%) of the trends. We then combined and simplified similar trends to reduce the 
number to 32 (Figure 1 - Flow diagram to outline study process for identifying 
research priority areas). To ratify the validity of the trends for palliative care, we 
conducted a focused literature review to identify examples where these technologies 












Delphi Questionnaire Development 
We developed 32 items for inclusion in the Delphi questionnaire, which reflected the 
32 trends identified from the Future Today Institute Report (see Figure 1 - Flow 
diagram to outline study process for identifying research priority areas). We used 
Google Forms[31] to develop the survey. We designed the questionnaire to collect 
demographic information (geographic location, age, occupation), and individuals’ 
rating of importance for each item via a 5-point Likert scale (1 = low priority, 5 = high 
priority). To ensure that the survey questions were appropriate, we conducted a local 
pre-study pilot of the questionnaire and supporting materials (Appendix 2 – ‘Delphi 
Questionnaire’ and Appendix 3 - ‘Scoping review’).  
 
Participant Recruitment and Consent  
We solicited a convenience sample of professionals working in palliative care 
(including doctors, nurses, social workers, therapists, pharmacists, spiritual care 
staff, managers etc. etc.) who were interest in technological innovation. We used 
professional networks, social media and email to contact individuals (Appendix 4 - 
Summary of the networks used to invite palliative care professionals to participate). 
Consenting participants accessed the study material online to complete an electronic 
consent form and the 1st round Delphi questionnaire. We invited participants who 
completed the 1st round questionnaire to participate in the 2nd round.  
 
Ethical approval 
This study was approved by the University of Liverpool Ethics Committee (study 
approval number 3564). 
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Data collection and analysis 
Quantitative statistical analyses of participants ratings were undertaken with the 
statistical software package SPSS 22.0. We used the Interquartile Range (IQR) to 
determine the level of agreement on the five-point scales for each ‘area’ on the 
questionnaire. The justification for the levels of agreement were based on thresholds 
previously used in palliative care Delphi studies, which used a 5-point Likert scale to 
determine agreement (Appendix 5: Interquartile Range to be used to guide the Level 
of Agreement for Delphi responses).[22, 32] We emailed a summary of the 1st round 
Delphi results to each participant. The email included the following information: (i) a 
summary of how the participant rated each item in the first Delphi round, and (ii) a 
summary of all participants’ responses for each item (pooled level of agreement). We 
provided this information so participants could consider whether they wished to rank 
items differently in the 2nd Delphi round, based on the ranking data generated by 
other participants.  
 
Round 2 Delphi questionnaire 
We provided participants with an electronic link to access the 2nd round Delphi 
questionnaire. We asked participants to answer the same questions that were 
included in the first-round questionnaire. Participants were required to complete the 
questionnaire within 4 weeks. We analysed responses from the 2nd questionnaire by 
IQR to provide a final list of items according to their level of agreement.  
 
Final consensus meeting and voting 
We organised a consensus meeting to agree the trend list as the final stage of the 
Delphi process.[22] We invited all participants to attend the meeting at the University 
of Liverpool, UK. We divided participants into two groups. We attempted to ensure 
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the groups were similar by allocating individuals according to their gender, 
experience and occupation. We provided participants with the Delphi results, via (i) 
an oral presentation and (ii) a written summary. ACN and TMc acted as group 
facilitators and ACN chaired the meeting. We facilitated group discussion and voting. 
Each item was discussed and debated, and a ‘raised-hand’ vote was undertaken 
within each group to determine if each item was included or excluded from the final 
list. 
 
After voting, we compared the outcomes for both groups. We included items if both 
groups voted for their inclusion. Similarly, we excluded items if both groups voted for 
exclusion. When the groups disagreed (i.e., one group voting for inclusion and the 
other voting for exclusion), we facilitated debate with both groups together, which 
was followed by rounds of voting until consensus was achieved.  
 
Public engagement workshop 
Following the Consensus meeting, we conducted a public engagement workshop 
with lay representatives to determine their views on the agreed priorities. We used 
volunteer coordinators from Marie Curie Hospice Liverpool and Liverpool University 
Hospitals NHS Foundation Trust, to invite palliative care volunteers (by telephone 
and email).  
RESULTS 
 
Round 1 Delphi Questionnaire 
Round 1 included 103 people participants (Table 1 - Demographics of study 
participants). The median age of participants was 45 years. Most participants were 
female (n = 65, 63.1%) and had a clinical background (n = 74, 72%). Participants 
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represented 11 countries, most commonly the United Kingdom (n = 88, 85.4%). Most 
trend items (n = 25, 78%) achieved a median priority rating of 4 or 5 (Appendix 6: 
Level of agreement for each ‘priority area’ following both Delphi rounds), which 
suggested that participants considered most items were important.  
 
Round 2 Delphi  
Fifty-five (53%) of the round 1 participants completed the round 2 questionnaire. The 
median age was 44 years, which was similar to round 1. More women than men 
completed the questionnaire (n = 32, 58.2%). The distribution of occupations was 
similar across both rounds. Fewer countries (n = 8) were represented among the 
final sample. The final IQR analysis (Appendix 6: Level of agreement for each 
‘priority area’ following both Delphi rounds) demonstrates that most items (n = 21, 
65.6%) had low levels of agreement, with two (6.3%) and nine (28.1%) items 
achieving moderate and high levels of agreement respectively.  
 
Consensus meeting and final list of priorities 
Eleven people participated in the consensus meeting (10.7% of total participants and 
20% of second round participants). The median age of participants was 44, and most 
were female (n = 7, 63.6%). All participants were based in the UK and were mostly 
from clinical (n = 6, 55%) or academic backgrounds (n = 4, 36%). The debate 
resulted in agreement, rejection, modification (rewording and combination) of trends, 
and the addition of a new item, digital legacy (Appendix 7: Voting outcomes for 
consensus meeting). We classified the priorities into eight topic areas which were: 
big data, mobile devices, telehealth/telemedicine, virtual reality, artificial intelligence, 
the smart home, biotechnology and digital legacy (Table 2 - Final list of priorities). 
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Public Engagement Event 
We conducted the public engagement event at Marie Curie Hospice Liverpool, UK, 
which was attended by six lay representatives, two staff members (nurse and doctor) 
and a medical student. We began the meeting with a presentation to discuss 
importance of studying technology in palliative care. We then presented an overview 
of the Delphi outcomes, the research topic areas and the identified priorities. We 
allocated attendees into two groups, and we (ACN and SS) facilitated two separate 
discussions (each lasting 45 minutes) with each group. Discussion 1 involved 
discussion about the priorities from the big data, artificial intelligence and 
biotechnology topic areas. Discussion 2 involved discussion about priorities from the 
telehealth & telemedicine, mobile devices and wearables, smart home, virtual reality 
and digital legacy topic areas.  We asked attendees for their views on priorities to 
determine their views on the appropriateness, and to identify areas that they believe 
warranted further study or clarification. Further information about the public 
engagement meeting is presented in the appendices (Appendix 8 – Technology in 
Palliative Care Public Engagement Event information). 
 
Our public representatives recommended that future research should: (1) ensure a 
human centre co-design approach to ensure that technologies are designed 
according to the needs of individuals and (2) that appropriate governance processes 
should be in place to evaluate efficacy, effectiveness and ethical issues of current 






Table 1: Demographics of study participants 
Characteristic First round Second round Consensus 
meeting 
Participants (N) 103 55 11 
Medan age, years 
(range) 
45 (22 -74) 44 (22 – 74) 44 (29 - 62) 
Gender (n, %)    
Male 38 (36.9) 23 (41.8) 4 (36.3) 
Female 65 (63.1) 32 (58.2) 7 (63.6) 
Location (n, %)    
UK 88 (85.4) 47 (85.5) 11 (100) 
USA 4 (3.9) 1 (1.8) - 
Germany 2 (1.9) 2 (2.6) - 
The Netherlands 2 (1.9) 1 (1.8) - 
Saudi Arabia 1 (1.0) - - 
Canada 1 (1.0) 1 (1.8) - 
Brazil 1 (1.0) 1 (1.8) - 
Italy 1 (1.0) - - 
Sweden  1 (1.0) - - 
Argentina 1 (1.0) 1 (1.8) - 
Austria 1 (1.0) 1 (1.8) - 
   - 
Occupation (n, %)    
Clinical 
(nurse/doctor) 
74 (71.9) 38 (69.1) 6 (54.5) 
 15 
Academic 16 (15.6) 11 (20.0) 4 (36.4) 
Healthcare manager 4 (3.9) 2 (3.6) 1 (9.1) 
Lay person 3 (2.9) 3 (5.5) - 
Allied health 
professional 
2 (1.9) 1 (1.8)  
Chaplaincy 2 (1.9) - - 
Information 
technology 






Table 2:  Final list of priorities 
Topic area Priority Potential areas for further study 





a) Use of Telehealth and 
telemedicine to support patients 
and caregivers  
- How can the telehealth 
systems be best used to 
provide remote support for 
patients and caregivers? 
- How can video-calling 
technology be used by 
health professionals to 
deliver palliative care? 
Artificial 
intelligence 
b) The use of different AI 
methodologies (e.g., Machine 
Learning, Natural Language 
Processing (NLP), deep 
learning, neural networks) be 
used for prediction and 
screening in palliative care. 
 
- How can algorithms for 
prediction and screening be 
developed safely and 
effectively for palliative care 
patients? 
- How can algorithmic driven 
data be used for palliative 
care research. 
- What are the ethical and 
legal issues concerning use 
of AI in palliative care? 
- How can bias be prevented, 
identified and addressed? 
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c) Ethical and moral issues 
concerning use of artificial 
intelligence in palliative care.  
- What are the ethical, legal, 
security and privacy issues 
of using artificial intelligence 
palliative care? 
- How can bias in AI 
applications be identified and 
addressed?  
- Who is responsible for 
maintaining trust in using AI 
in palliative care? 
Big data d) Collection and use of big 
data, from Electronic Health 
Records (EHR) systems. 
- How can electronic health 
records be best designed to 
optimise use of big data in 
palliative care? 
- How can big data be used to 
improve palliative care on an 
individual and population 
health perspective? 
- What are the 
training/education needs of 
staff regarding the use of big 
data in palliative care. 
e) Governance, data security 
and regulation of big data use 
in palliative care.  
- What are the responsibilities 
of stakeholders in the design 
and use big data, across 
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different aspects of palliative 
care? 
- What data security 
considerations are required 
for the use of big data in 
palliative care? 
f) Ethical Challenges of big data 
health research:  
- What are the ethical issues 
in palliative care research 
using big data? 
- What are the implications for 
informed consent and 
participation in big data 
research? 
g) Role of ‘big data’ and 
artificial intelligence for 
palliative care population health 
management  
- How can novel data analysis 
methods use population 





h) Use of mobile devices to 
support communication, patient 
monitoring and patient reported 
outcomes (PROs)  
- How can data from mobile 
devices be used to monitor 
physical and emotional 
wellbeing? 
- How can mobile devices 




- How can mobile devices be 
used to support 
communication and 
information sharing with 
patients, caregivers and 
health professionals? 
- How can mobile devices be 
used for therapeutic care 
delivery? 
- How can advance care 
planning discussions be best 
supported, documented and 
shared. 
i) Development of apps for 
clinical use in palliative care  
- How can apps be designed 
to ensure safety, efficacy 
and accuracy? 
- What are the interoperability 
considerations of app 
design/development? 
- How can risks of app 
assessment be identified 
and managed? 
j) Patient-Generated Health 
Data (PGHD) to promote 
personalised palliative care  
- What data should be 
collected and what 
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mechanisms should be used 
for this? 
- How can sensor-based 
technologies be best used to 
support generation of 
PGHD? 
- How can PGHD be used for 
active and passive palliative 
care management? 
k) Wearable Health Trackers 
for Physical Activity Change 
Detection (PACD)  
- How can wearable health 
trackers support physical 
activity for people with 
palliative care needs? 
- Can wearable technologies 
be used to detect physical 
decline in serious illness? 
- Can wearable technologies 




l) Use of virtual reality (VR) for 
symptom management in 
palliative care  
- How can VR be used for 
symptom management in 
palliative care? 
- What VR equipment, 
processes and systems offer 
 21 




m) Use of Smart Home 
technologies (e.g., Internet of 
Things) and sensors for 
monitoring of health status  
- How can the Internet of 
Things technologies be used 
to provide palliative care at 
home?  
- How can smart (home) 
assistants support palliative 
care delivery? 
- What are the privacy, ethical 
and legal issues related to 
the smart home in palliative 
care? 
Biotechnology n) Genome profiling and 
Personalised Medicine  
- How can personalised 
medicine to improve 
symptom management or 
disease specific 
management in palliative 
care? 
o) Genetic editing and 
biomarker technology for earlier 
disease detection and possible 
disease 
management/prevention  
- What palliative care 
complications could 
potentially benefit from early 
detection or prevention (e.g., 
to predict individuals 
susceptible to development 
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of metastases, pathological 
fracture or hypercalcaemia)?  
- Can genetic editing be used 
to improve management for 
palliative care? 
Digital legacy p) Use of technologies which 
contribute to digital legacy in 
palliative care 
- How can different forms of 
digital material be used 
actively to support patients 
and caregivers to create a 
‘digital legacy’? 
- How should digital legacy be 
managed after death? 
- What are the potential risks 
and ethical issues related to 






Summary of main findings 
This is first study to identify digital health research priorities for palliative care and 
provides guidance for researchers, funders and policy makers to consider areas for 
future research and development.  We identified 16 priorities areas, which involved 
many applications of technologies, including care for patients and caregivers, self-
management and reporting of disease, education and training, communication, care 
coordination and research methodology. We summarised the priority areas into eight 
topic areas, which were: big data, mobile devices, telehealth and telemedicine, 
virtual reality, artificial intelligence, the smart home, biotechnology and digital legacy. 
 
Contribution and strengths of this paper 
The outcomes of our detailed analysis (involving a modified Delphi process and 
patient engagement workshop) indicates further digital health research is needed to 
study how technology can be best used to support palliative care. Our paper is the 
first priority-setting paper for palliative care digital health and provides a foundation 
for digital health focused palliative care research. 
 
Telehealth and telemedicine 
Prior to the novel coronavirus disease 2019 (COVID19) pandemic, researchers 
highlighted the potential to use telehealth (i.e., technology to support remote clinical 
access), and telemedicine (i.e., technology to support remote clinical care delivery) 
in palliative care. These technologies are increasingly used in palliative care;[33, 34] 
however, many are unevaluated for use in real-world settings.[19, 35] Beyond the 
pandemic, researchers can consider how these technologies can improve palliative 
care access (e.g. for remote communities, hard to reach groups) to support new 
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models of care (e.g. tele-palliative care clinics). It is also important to consider 
barriers (e.g., equity of access, privacy and security considerations) facilitators (ease 
of use, incentives) and use-cases (e.g., reasons for use) for adoption of telehealth 
and telemedicine in palliative care.  
 
Artificial Intelligence 
Artificial intelligence (AI) is often used as an umbrella term to describe a number of 
processes (e.g. Machine Learning, Natural Language Processing (NLP), deep 
learning, neural networks).[36] Clinicians and researchers are increasingly using AI 
to predict survival,[37-40] classify pain severity,[41, 42] identify quality indicators,[43, 
44] and to identify serious illness conversations from electronic healthcare 
records.[45] However, most of these studies are exploratory and do not provide 
recommendations for clinical practice.[18] Therefore, researchers should explore 
how different AI techniques can support palliative care research and practice, with 
consideration to the ethical issues associated with these methods. 
 
Big data 
Big data describes the large amounts of (previously unmanageable) data, which can 
now be processed by modern-day computer analysis techniques. The opportunities 
to use routine data to support palliative care decisions for populations and individuals 
has previously been reported.[46, 47] Currently, there is no consensus for how non-
traditional sources of big-data can be meaningfully used in palliative care. For 
example, there is potential to use patient-generated data (e.g., from wearables) for 
quality-of-life assessments. Furthermore, open source genomic databases may 
provide opportunities to study relationships between genetics and health, to inform 
how data can be used for disease management. Social media, and other forms of 
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online data, are increasingly used to support public and professional communication, 
and to gain insight on the public attitudes to palliative care.[48-51] Consequently, 
researchers should identify what data to collect, and how to best use both traditional 
and non-traditional sources of palliative care big data.[18, 52, 53]  
 
Mobile devices and wearables 
Many studies have described how mobile devices and wearables can support 
palliative care (e.g. remote monitoring of physical activity and symptoms, to deliver 
wellbeing activity, for documentation of advance care planning, education 
access/delivery and guideline access).[54-58] The capability of these devices to 
collect and store data are increasing; therefore, it is important to determine how this 
data can be meaningfully used.[59, 60] Researchers have previously described how 
patient-reported outcomes (PRO) can improve palliative care patients,[61-63] 
however, further work is needed to explore how this technology can best support 
PRO collection (and use) in real world settings.[64, 65] It is important to examine 
how mobile devices are designed to meet the requirements of palliative care 
users.[66] Furthermore, studies should provide more information of how mobile 




Virtual reality (VR) is a human-computer interface technology that uses visual 
graphics, sounds and other sensory input to create an interactive computer 
world.[69] Previous studies have described the potential to use VR to support 
psycho-social symptoms and wellbeing; however, most work is unevaluated so 
further research is needed.[70-73] We recognise the potential of VR to support 
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palliative care education;[74, 75] however, the Consensus group did not identify this 
as a current priority. Following our study, we recognize that the COVID19 pandemic 
has accelerated the use of virtual learning environments for medical education,[76] 
particularly with the potential to use VR for communication skills training.[74] 
Consequently, it is possible that VR for education would rate higher as a priority if 
this study were repeated. 
 
The smart home 
A smart home describes a living environment where sensor-based systems and 
internet-connected devices (the Internet of Things) are used for remote monitoring 
and automation of appliances, such as lighting and heating.[77] Previous studies 
illustrate how various technologies can support care for people experiencing decline 
in their physical function (e.g. virtual assistants and supportive robotics), which 
highlights the wider role these technologies may have in practice.[78] Consequently, 
future work should explore the usefulness of smart home technologies in supporting 
physical function, and the legal, privacy and ethical issues associated with these 
developments.[53] [3, 67, 77-79] 
 
Biotechnology 
Biotechnology involves the combination of technology with living things.[80] Palliative 
care related developments include use biomarkers to predict survival,[81, 82] 
constipation, [83]delirium,[84, 85] and the personalisation of cancer pain according to 
genetics.[86-88] Consequently, it is possible to imagine future scenarios where 
technologies are used for early identification (and prediction) of clinical issues, 
facilitating personalised treatment for the individual (e.g. early identification and 




A digital legacy is the digital information available about someone after death, such 
as social media, photos, videos and gaming profiles.[89] The volume of digital 
information generated by citizens is increasing, which creates new challenges after 
death.[90] The increasing use of cloud storage and social media is contributing to 
uncertainty of data ownership, which creates difficulties for caregivers to manage the 
digital legacy of the deceased. Studies demonstrate that healthcare professionals 
can positively support their patients to manage their digital legacy.[89, 91] [92] 
However, digital legacy is not routinely discussed in clinical practice, which means 
that we generally do not know how individuals want their data to be managed after 
death.[93]  Therefore, we believe that researchers should explore how patients and 
caregivers can be supported to manage their digital legacy after death, with 
exploration on the different methods and materials that can be used. 
 
Relation to previous work in this area and areas of interest following the novel 
COVID19 pandemic 
Our study is synergistic with previous work, which has been conducted across the 
topic areas.[19, 35] We acknowledge that our study pre-dates the pandemic and it is 
possible that the priorities we identified may now have shifted. However, we believe 
our research findings are valid as the digital health innovations adopted during the 
pandemic are in sync with our priority list. (Appendix 9 - Examples of technologies 
used in palliative care during the COVID19 pandemic).[34, 35] For example, 
telehealth was commonly used during the pandemic, with many palliative care 
services using this to provide remote clinical support,[94-106] to communicate[107] 
and for education.[108] Technologies were used to maintain connection, and to 
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develop communities of palliative care practice.[109] [110] VR was used to provide 
psychological care and symptom management.[111] [112] In general, the findings 
these studies describe potential benefits of digital health; however, the rapid 
implementation of these technologies has created a number of challenges (e.g., 
technical issues, data security and wellbeing considerations) which, require further 
evaluation.[107] We are encouraged that these palliative care digital health studies, 
conducted during the pandemic, are within the scope of our identified priorities. The 
evidence suggests that the pandemic has accelerated adoption of digital health in 
palliative care practice (and related research in these areas), rather than shift to 
different priorities to the ones we identified. We expect there to be development and 
evolution of digital health research areas, which may be new ‘priorities’ or linked to 
existing areas. For example, artificial intelligence driven data analysis of data from 
‘internet of things’ devices. Consequently, we believe that the COVID19 pandemic 
has elevated the importance of digital health, as health organisations use technology 
to support palliative care post-pandemic. 
 
Palliative care digital health priorities in regions unrepresented in this study 
Although geographic regions are unrepresented in our study (e.g. Asia Pacific, 
Australasian or African regions), studies from these countries are consistent with our 
outcomes as they describe the emerging importance of palliative care digital health. 
Australian palliative care providers report digital health priorities which are like those 
identified in our study, with providers wanting innovations in the areas of client health 
records, telehealth, and personal health tracking.[113] However, digital health 
priorities are likely to differ between countries due to geopolitical and socioeconomic 
drivers. For example, in Sub-Saharan African, digital health is not as established as 
other developed regions.[114] Consequently, Sub-Saharan African stakeholders 
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describe digital health as part of a wider vision in this region, to potentially improve 
data development and use to support development of healthcare services.[115, 116] 
Palliative care is a growing discipline in the Asia Pacific region and current research 
describing digital priorities are limited, although there is acknowledgement that digital 
health can play an important role in supporting education and training.[117] 
 
Limitations 
It is possible that recent developments were not reflected in the priority list due to 
ongoing advancement of healthcare technologies. For example, the FTI trends list is 
now in its 2021 version and includes new trends such as, home medical laboratory 
tests and remote metabolic monitoring. Therefore, it is possible that relevant areas 
are absent from this analysis. Also, a weakness of digital health research is the rapid 
change associated with technology, which may cause the findings of this study to 
lose relevancy over time.  
 
Our decision to reduce the number of trends from 95 to 32 items, has broadened the 
focus of the list, which means it is possible that more specific and technical areas 
were not explored in greater depth (e.g., faceprints, voiceprints, chatbots etc etc). It 
is also possible that our Delphi participants will have different views on priority of 
some areas post COVID19, due to the observed increase of digital health in practice. 
It is possible, due to the novel nature of some areas, that participants gave more 
priority to familiar areas and therefore, less priority to unfamiliar areas. 
Questionnaires were mostly completed by participants arising from English-speaking 
countries, meaning that the experience of non-English speaking populations may not 
be reflected. Specifically, our outcomes may not represent the Asia Pacific, 
Australasian or African regions, as we had no responses from these areas. 
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Furthermore, the final priority list may not represent non-UK healthcare systems, as 
the consensus meeting was only attended by UK residents. We acknowledge that 
people from different professional backgrounds (including cultures and settings) may 
assign different levels of priority to trends, due their experience, work-requirements 
and personal beliefs. As most participants were clinically-focused, it is possible that 
the priorities were orientated to clinical-utility, rather than methodology.  
 
Relevance to research, practice and policy 
Decision-makers should ensure that technology is relevant to the needs of the 
palliative care user, as these requirements will influence the design, use and function 
of systems.[118, 119] For example, healthcare professionals may generally use 
technology to access patient data and communicate with other professionals, 
whereas patients may wish to access their own health data and to contact healthcare 
services. Further research is needed to develop specific use-cases for these 
scenarios, to ensure that the technology can be used meaningfully to achieve the 
intended outcomes. Furthermore, as the user requirements of people with palliative 
care needs may differ from the general population[120] and because we lack 
resources for wide-spread implementation of all technologies currently, it is important 
that digital health studies provide the data needed for determine best practice, and to 
help identify the barriers and facilitators for adoption.  
Researchers should use appropriate methodologies to explore these questions and 
should also study associated areas, such as ethical issues, data security, and 
design. It is important that researchers work with the public, as the comments of the 
lay representatives in our study (from both the consensus meeting and the public 
engagement workshop) described concerns about the use of personal data. 
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Policymakers should consider issues related to governance and ethics of current, 
and future, digital systems. From a design perspective, we suggest that palliative 
care professionals work collaboratively with creative industries (e.g., designers, 
developers and engineers) to ensure that designed technologies fulfil the user 
requirements for specific palliative care use-cases. 
 
Conclusions 
The identified priorities in this paper represent a wide range of important emerging 
areas in the field of digital health, personalised medicine, and data science. Human-
centred design and robust governance systems should be considered in future 
research. Transdisciplinary studies using appropriate methodologies are required to 
further study this priority list. It is important that the risks of using these technologies 
in palliative care are properly addressed to ensure that these tools are used 
meaningfully, wisely and safely and do not cause unintentional harm. 
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Figure 1: Flow diagram to outline study process for identifying research priority areas 
 
Table 1: Demographics of study participants for the Delphi questionnaires and 
consensus meeting 
Table 2:  Final list of priorities 
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